SCYX
SCYNEXIS INC · Healthcare · Market cap $48.4M
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Sep 22, 2026
Angulo Gonzalez David
SCYNEXIS INC (SCYX) has 11 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Sep 22, 2026.
Inside the rolling window, 1 insider at SCYNEXIS INC reported 1 open-market purchase and no open-market sales. The most recent open-market filing is a purchase of 108,695 shares by Chief Executive Officer Angulo Gonzalez David, dated Apr 1, 2026.
- Industry:Medical - Pharmaceuticals
- CEO:David Angulo
- Employees:18
- HQ:Jersey City, NJ, US
- IPO:2014-05-02
| Source | |||||||
|---|---|---|---|---|---|---|---|
Angulo Gonzalez DavidFirst filing | Chief Executive Officer | Purchase | 108,695 | — | Apr 2 | -31.6% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does SCYX have?
SCYNEXIS INC (SCYX) has 11 SEC Form 4 filings (11 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Sep 22, 2026.
When was the most recent SEC Form 4 filing for SCYX?
The most recent Form 4 filing for SCYX on Tracefour is dated Sep 22, 2026.
Can I get alerts for SCYX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at SCYNEXIS INC (SCYX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
SCYNEXIS INC is in the Healthcare sector.